Annovis Bio Inc
ANVS
Market Cap$39.95M
Close$
$0.86
63.8% downside
Current Fair Value
63.8% downsideOvervalued by 63.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $39.95 Million |
|---|---|
| Enterprise Value | $-20,826,039,290.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2018.5 |
| Beta | 1.62 |
| Outstanding Shares | 17,431,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 1.18 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.07 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Annovis Bio Inc
CEO: Maria Maccecchini